The Influence of Radioligand Therapy on Immunogenicity Against SARS-CoV-2—A Retrospective Single-Arm Cohort Study of Metastatic Prostate Cancer Patients Receiving PSMA Radioligand Therapy †. Here, FOLH1 is linked to prostate carcinoma.